ZYMOGENETICS, INC. – Trademark Portfolio
Entity Type: 03
ZYMOGENETICS, INC. has 72 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include RECOTHROM. The portfolio includes 1 registered trademark. Filings span 5 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 1 (Chemicals). This trademark owner is based in SEATTLE, WA.
2121 NORTH 35TH STREET
SEATTLE, WA 98103
Showing of trademarks Trademarks
Trademark Classifications
ZYMOGENETICS, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ZYMOGENETICS, INC. have?
ZYMOGENETICS, INC. has 72 U.S. trademarks filed with the USPTO. Of these, 1 registered, 61 abandoned, 10 cancelled.
What trademark classes does ZYMOGENETICS, INC. file in?
ZYMOGENETICS, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ZYMOGENETICS, INC.'s most well-known trademarks?
ZYMOGENETICS, INC.'s registered trademark portfolio includes well-known marks such as RECOTHROM. These are among 1 currently registered trademark in the portfolio.
What is ZYMOGENETICS, INC.'s trademark registration success rate?
ZYMOGENETICS, INC. has a 1% trademark registration rate, with 1 out of 72 resolved applications resulting in successful registration. Currently, 0 applications are pending review.